Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1992-12-07
1994-11-22
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119
Patent
active
053669967
ABSTRACT:
A therapeutic process for treating anemias in primates, including man, particularly those anemias of genetic origin including sickle-cell anemia, which comprises administering to an anemic primate an amount of a polyhydroxy benzoic, mandelic or phenylacetic acid derivative as specified at a dose level sufficient to increase fetal hemoglobin.
REFERENCES:
patent: 4263322 (1981-04-01), van't Riet et al.
patent: 4448730 (1984-05-01), van't Riet et al.
Letvin et al New Eng. J. Med. 310, 869 (1984).
Goldberg et al. id. 323, 366 (1990).
Charache et al, Blood 69 109 (1987).
Vieth et al, New Eng. J. Med. 313, 1571 (1985).
Constantoulakis et al, Blood 77, 1326 (1991).
Merck Manual (15th ed.): Anemias p. 277, 1987.
(Abstract) Pace et al, Blood 78 S1 203a (1991).
Dover & Charache, Annal N.Y. Academy of Science 565, 222 (1989).
Elford Howard L.
van't Riet Bartholomeus
Cintins Marianne M.
Moezie M.
Rowe James L.
LandOfFree
Method of treating hemoglobinopathies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hemoglobinopathies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hemoglobinopathies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1991728